---

---

tags : Drug    crawled time : 19:00   

save search

---

European Medicines Agency (EMA) Grants Orphan Drug Designation for Moleculin's Treatment of Acute Myeloid Leukemia (AML)
Published: 2024-04-18 (Crawled : 19:00) - biospace.com/
MBRX | $4.45 3.49% 3.37% 7.4K |

Health Technology

| 0.47% | O: 4.91% H: 11.36% C: 0.67%
drug treatment designation for grants leukemia

---

Coya Therapeutics to Participate in the 3rd Annual ALS Drug Development Summit
Published: 2024-04-18 (Crawled : 19:00) - biospace.com/
COYA | News | $7.995 0.06% 0.06% 24K |

| -2.2% | O: -1.1% H: 0.0% C: 0.0%
drug als therapeutics development

---

Odyssey Therapeutics Announces Strategic Collaboration to Advance AI-Driven Small Molecule Drug Discovery
Published: 2024-04-04 (Crawled : 19:00) - biospace.com/
JNJ | News | $149.56 0.3% 0.0% 9.1M |

Health Technology

| -5.48% | O: -1.51% H: 0.0% C: 0.0%
drug collaboration therapeutics

---

U.S. Food and Drug Administration (FDA) Grants Full Approval for ELAHERE® (mirvetuximab soravtansine-gynx) for Certain Ovarian Cancer Patients
Published: 2024-03-22 (Crawled : 19:00) - prnewswire.com
ABBV | News | $169.54 0.98% -0.91% 4.1M |

Health Technology

| Email alert Add to watchlist
elahere drug approval food cancer grants

---

Unveiling the Future of Drug Testing: Psychemedics Introduces Advanced 5-Panel Drug ScreenPsychemedics’ FDA-cleared alternative 5-panel drug screen replaces marijuana with fentanyl.
Published: 2023-10-27 (Crawled : 19:00) - biospace.com/
PMD | $2.655 5.54% 940 |

Health Services

| 12.29% | O: 2.12% H: 2.07% C: 1.66%
drug alternative

---

Veracyte Announces SITC 2023 Presentations Offering New Insight into Immuno-oncology Drug Development
Published: 2023-10-27 (Crawled : 19:00) - biospace.com/
VCYT | News | $19.82 -0.15% -0.15% 560K |

Health Technology

| -2.79% | O: 1.22% H: 0.0% C: -4.6%
drug offering

---

Halozyme Announces Positive Clinical Data of its High-Volume Auto-Injector Demonstrating Successful Rapid Subcutaneous Drug Delivery
Published: 2023-10-16 (Crawled : 19:00) - biospace.com/
HALO M | $38.94 0.59% 0.59% 560K |

Health Technology

| 5.91% | O: 1.01% H: 0.68% C: 0.24%
drug rapid positive

---

Update: Halozyme Announces Presentation of Positive Clinical Data of its High-Volume Auto-Injector Demonstrating Successful Rapid Subcutaneous Drug Delivery at 13th Annual PODD: Partnership Opportunities in Drug Delivery Conference
Published: 2023-10-16 (Crawled : 19:00) - prnewswire.com
HALO M | $38.94 0.59% 0.59% 560K |

Health Technology

| 4.59% | O: -1.32% H: 4.47% C: 2.85%
partnership drug conference rapid presentation positive

---

National Institutes of Health Awards $45.1 Million NINDS Grant for CNM-Au8® Study in ALSFunding to Support Research and Expanded Access of Investigational Drug in ALS
Published: 2023-10-05 (Crawled : 19:00) - biospace.com/
CLNN 4 | $0.3352 0.66% 0.66% 310K |

| -33.21% | O: 4.43% H: 27.91% C: 5.31%
au8 drug health als awards research grant study

---

NRx Pharmaceuticals Announces FDA Permission to Proceed on Investigational New Drug (IND) Application for NRX-101 to Treat Chronic Pain
Published: 2023-10-02 (Crawled : 19:00) - biospace.com/
NRXP 5 d | $3.1 3.33% 3.23% 110K |

Manufacturing

| 1053.85% | O: 4.81% H: 5.72% C: 5.36%
nrx-101 fda drug permission treat pharmaceuticals application

---

Calliditas Therapeutics granted orphan drug designation by the FDA for the treatment of Alport syndrome with setanaxib
Published: 2023-09-27 (Crawled : 19:00) - biospace.com/
CALT | $18.0825 -1.71% 1.9K |

Health Technology

| -1.03% | O: 2.26% H: 1.71% C: -0.54%
fda drug granted treatment designation therapeutics

---

Wexler Boley & Elgersma LLP, Miller Law LLC, Hilliard Shadowen LLP, Motley Rice LLC, and Spector Roseman & Kodroff P.C. Announce a $30 Million Class Action Settlement for Those Who May Have Purchased or Provided Reimbursement for the Drug Suboxone or Generic Suboxone
Published: 2023-08-28 (Crawled : 19:00) - prnewswire.com
RBGPF | News | $52.06 6.46% 4.8K |

Consumer Non-Durables

| -29.21% | O: -1.55% H: 0.59% C: 0.59%
RBGLY | News | $10.59 -2.05% 850K |

Manufacturing

| -26.3% | O: 0.56% H: 0.67% C: 0.14%
drug rice

---

North America Dominates Global Drug Discovery Informatics Market in 2022, Asia-Pacific to Witness Fastest Growth
Published: 2023-07-20 (Crawled : 19:00) - prnewswire.com
TMO | News | $574.59 4.78% -1.12% 2.5M |

Health Technology

| 1.88% | O: 0.07% H: 4.84% C: 4.37%
ORCL | News | $115.09 0.49% 0.02% 5.5M |

Technology Services

| -1.16% | O: 0.53% H: 2.39% C: 1.0%
IBM | $182.19 0.16% 0.63% 5.9M |

Technology Services

| 31.45% | O: -0.12% H: 1.14% C: 0.53%
ACN | News S | $316.83 -0.19% 0.0% 2M |

Technology Services

| 1.58% | O: 0.3% H: 0.0% C: 0.0%
america drug global growth market

---

U.S. Food and Drug Administration Approves BioMarin's ROCTAVIAN™ (valoctocogene roxaparvovec-rvox), the First and Only Gene Therapy for Adults with Severe Hemophilia A
Published: 2023-06-29 (Crawled : 19:00) - investors.biomarin.com
BMRN | $92.06 2.87% 2.79% 1.3M |

Health Technology

| 0.63% | O: 1.2% H: 1.97% C: -3.69%
drug food therapy

---

Soligenix Announces Scheduling of Type A Meeting with the U.S. FDA for HyBryte™ New Drug Application in the Treatment of Cutaneous T-Cell Lymphoma
Published: 2023-04-03 (Crawled : 19:00) - biospace.com/
SNGX | $0.4012 -1.13% -1.15% 450K |

Health Technology

| -79.19% | O: -3.55% H: 11.45% C: 6.32%
fda drug t-cell treatment meeting application

---

High-Performance Liquid Chromatography HPLC Global Market Report 2023: Rising Importance of HPLC Tests in Drug Approvals Drives Adoption
Published: 2023-03-15 (Crawled : 19:00) - prnewswire.com
TMO | News | $574.59 4.78% -1.12% 2.5M |

Health Technology

| 1.05% | O: -0.54% H: 3.48% C: 3.21%
drug report global market

---

To Advance Health Equity for Ultrarare Diseases, We Need an ‘Orphan Drug Act 2.0’
Published: 2023-02-28 (Crawled : 19:00) - ultragenyx.com
RARE F | $45.06 3.14% 3.04% 840K |

Health Technology

| -1.8% | O: 0.58% H: 2.95% C: 2.01%
drug health

---

U.S. Real-World Evidence Solutions Market Report 2022: Delays in Drug Development and the Subsequent Increase in Development Costs Drives Growth
Published: 2023-02-21 (Crawled : 19:00) - prnewswire.com
UNH | $486.18 -1.03% 0.15% 3.6M |

Health Services

| -0.02% | O: 0.31% H: 0.22% C: -0.8%
ORCL | News | $115.09 0.49% 0.02% 5.5M |

Technology Services

| 32.87% | O: 0.56% H: 0.58% C: -0.42%
ICLR | News | $306.16 2.76% 2.68% 860K |

Health Technology

| 33.39% | O: -0.47% H: 0.55% C: -0.26%
CTSH | $67.75 -0.66% -0.66% 2.8M |

Technology Services

| 5.47% | O: 0.14% H: 0.6% C: -0.48%
drug solutions report growth market

---

Blockchain Technology in Healthcare Market Report 2023: Drug Discovery and Clinical Trials Set to Present Opportunities
Published: 2023-01-31 (Crawled : 19:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -5.26% | O: 0.72% H: 0.0% C: 0.0%
SNY | News | $47.69 1.15% 1.13% 1.7M |

Health Technology

| -5.17% | O: -0.51% H: 0.0% C: 0.0%
trials drug report blockchain set technology market

---

Catalyst Pharmaceuticals Comments on FDA's Announcement of its Position on Orphan Drug Exclusivity In Light of the 11th Circuit Decision in Catalyst Pharmaceuticals, Inc. v. Becerra
Published: 2023-01-23 (Crawled : 19:00) - globenewswire.com
CPRX | News | $14.73 -2.45% -2.51% 990K |

Health Technology

| 2.3% | O: 0.2% H: 9.87% C: 8.99%
pharmaceuticals announcement drug

---

Gainers vs Losers

78%

22%

Top 10 Gainers

MTTR | News 4 | $4.6 164.37% 62.17% 28M |

AGBA | $2.94 135.2% 57.48% 66M |

Finance

EDBL | News | $6.46 71.81% 41.8% 2M |

MTC | $2.25 44.23% 30.67% 6M |

Technology Services

OPRT | News | $3.175 41.11% 29.13% 12M |

Finance

SHIM | $3.05 35.56% 26.23% 1.1M |

HKIT | $1.345 31.86% 24.16% 390K |

Technology Services

ABVC | $1.36 30.77% 23.53% 7.4M |

Wholesale Trade

OST | $0.512 28.0% 21.88% 290K |

POET | $1.59 27.2% 21.38% 4.2M |

Manufacturing

---

Your saved searches

---